◆英語タイトル：Senzime AB (SEZI) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA8011544
◆発行会社（調査会社）：
GlobalData
◆発行日：2017年12月22日
◆ページ数：32
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：スウェーデン
◆産業分野：医療機器
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
Summary
Senzime AB (Senzime) is a medical device company that develops patient-oriented monitoring systems. The company’s product include TetraGraph monitor, CliniSenz analyzer, and Onzurf probe. Its TetraGraph monitor stimulates, measures, analyzes and displays muscle function in surgical patients receiving neuromuscular blocking agents. Senzime’s portfolio of technologies includes bedside systems that enable automated and continuous measurement of biological substances as glucose and lactate in the blood and tissue fluid and patient-system for peri-operative monitoring of the neuromuscular function in patients undergoing depth of anesthesia. The company’s products are used in the areas of medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. Senzime is headquartered in Uppsala, Sweden.
Senzime AB (SEZI) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Senzime AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Senzime AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Senzime AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Senzime AB, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Senzime AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Senzime AB, Medical Equipment, Deal Details 10
Partnerships 10
Senzime Enters into Licesning Agreement with Fukuda Denshi 10
Senzime Enters into Distribution Agreement with Wardray Premise and LSR Healthcare 11
Equity Offering 12
Senzime Raises USD2.7 Million in Rights Offering of Shares 12
Senzime Raises USD2 Million in Rights Offering of Shares 13
Senzime Raises USD7 Million in Private Placement 14
Senzime Raises USD1.15 Million in Private Placement of Shares 15
Senzime Raises USD2.8 Million in Rights Offering of Shares 16
Senzime to Raise USD1.9 Million in Rights Offering of Shares 17
Senzime Raises USD1 Million in Rights Offering of Common Shares 18
Senzime Completes Rights Offering Of Shares For US$1 Million 19
Acquisition 20
Senzime Acquires Acacia Designs for USD10.2 Million 20
Senzime Acquires MD Biomedical 21
Senzime AB – Key Competitors 22
Senzime AB – Key Employees 23
Senzime AB – Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Financial Announcements 25
Nov 28, 2017: Senzime’s Interim report January – September 2017 25
Aug 31, 2017: Senzime’s Interim report January – June 2017 26
May 31, 2017: Senzime’s Interim report January – March 2017 27
Corporate Communications 29
Jun 07, 2016: Senzime strengthens management – hires new CFO and Director of Business Development 29
Legal and Regulatory 30
Jun 12, 2017: Senzime receives ISO 13485 certification 30
Feb 07, 2017: Senzime launches new website 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List of Tables
Senzime AB, Medical Equipment, Key Facts, 2016 2
Senzime AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Senzime AB, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Senzime AB, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Senzime AB, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Senzime AB, Deals By Market, 2011 to YTD 2017 8
Senzime AB, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Senzime Enters into Licesning Agreement with Fukuda Denshi 10
Senzime Enters into Distribution Agreement with Wardray Premise and LSR Healthcare 11
Senzime Raises USD2.7 Million in Rights Offering of Shares 12
Senzime Raises USD2 Million in Rights Offering of Shares 13
Senzime Raises USD7 Million in Private Placement 14
Senzime Raises USD1.15 Million in Private Placement of Shares 15
Senzime Raises USD2.8 Million in Rights Offering of Shares 16
Senzime to Raise USD1.9 Million in Rights Offering of Shares 17
Senzime Raises USD1 Million in Rights Offering of Common Shares 18
Senzime Completes Rights Offering Of Shares For US$1 Million 19
Senzime Acquires Acacia Designs for USD10.2 Million 20
Senzime Acquires MD Biomedical 21
Senzime AB, Key Competitors 22
Senzime AB, Key Employees 23
Senzime AB, Subsidiaries 24
